Clinical Trial

Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled Study

Name: Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled Study — clinical trial record (NCT07583511)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To compare the efficacy and safety between teniposide, cisplatin and serplulimab regimen and etoposide, cisplatin and serplulimab regimen in the treatment of extensive stage small lung cancer

Trial Details

NCT Number	NCT07583511
Lead Sponsor	Sun Yat-sen University
Conditions	Small-cell Lung Cancer
Enrollment	90 participants
Start Date	2024-02-01
Primary Completion	2027-05-01 (estimated)
Study Completion	2027-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-05-13